Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C1D nuclear receptor corepressor pseudogene 2 (C1DP2), also known as bA369J21.3, is a human pseudogene located in the genome and annotated as related to the C1D nuclear receptor corepressor gene[5][6]. As a pseudogene, C1DP2 does not encode a functional protein and is not considered a therapeutic target such as a receptor, enzyme, transporter, or similar molecule. While some pseudogenes are known to have non-coding regulatory functions, there is currently no published evidence supporting any biological function or disease association for C1DP2 specifically. C1DP2 should not be confused with its parent gene, C1D, which encodes a multifunctional protein involved in RNA metabolism, DNA repair, and apoptotic pathways[1][3][4][7]. Pseudogenes such as C1DP2 are sometimes transcribed and have emerging regulatory roles in gene expression, but no such functions have been reported for this pseudogene[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C1D nuclear receptor corepressor pseudogene 2 (C1DP2).